GWP.L Regulatory News (GWP)

GWP.L Information

There is currently no data for GWP

REMOVE ADS

Additional Listing

1 Sep 2005 11:14

GW Pharmaceuticals PLC01 September 2005 GW Pharmaceuticals plc ("the Company") Option exercise and application to AIM Pursuant to the exercise by a consultant of an option over 12,275 new ordinaryshares of 0.1 pence each in the Company ("New Ordinary Shares") at a price of20.52 pence per share, the Company has today issued and allotted the NewOrdinary Shares and applied for them to be admitted to the AlternativeInvestment Market of the London Stock Exchange. Such admission is expected tobecome effective on 9th September 2005. This information is provided by RNS The company news service from the London Stock Exchange

Date		Source	Headline
8th Sep 2015	2:37 pm	RNS	Block Listing Application
17th Aug 2015	9:14 am	RNS	Blocklisting Interim Review
6th Aug 2015	12:28 pm	RNS	Third Quarter 2015 Financial Results
6th Aug 2015	11:45 am	RNS	FDA Fast Track and EMA Orphan Designations for CBD
23rd Jul 2015	12:00 pm	RNS	Notice of Results
16th Jul 2015	4:15 pm	RNS	Appointment of Director
16th Jul 2015	10:40 am	RNS	Holding(s) in Company
9th Jul 2015	4:57 pm	RNS	Holding(s) in Company
9th Jul 2015	4:24 pm	RNS	Holding(s) in Company
7th Jul 2015	3:23 pm	RNS	Holding(s) in Company
30th Jun 2015	7:00 am	RNS	Director/PDMR Shareholding
24th Jun 2015	5:56 pm	RNS	Director/PDMR Shareholding
12th Jun 2015	5:39 pm	RNS	Director/PDMR Shareholding
11th Jun 2015	12:00 pm	RNS	Second Ph3 Pivotal Study of Epidiolex in LGS
1st Jun 2015	10:19 am	RNS	Block Listing Application
1st Jun 2015	7:54 am	RNS	Holding(s) in Company
1st Jun 2015	7:53 am	RNS	Holding(s) in Company
29th May 2015	11:13 am	RNS	Holding(s) in Company
19th May 2015	12:00 pm	RNS	Appoints US Executive; Relocates CEO to US
15th May 2015	5:43 pm	RNS	Purchase of Additional American Depositary Shares
11th May 2015	3:00 pm	RNS	Presenting at BAML 2015 Healthcare Conference
11th May 2015	12:00 pm	RNS	Half Yearly Report
11th May 2015	12:00 pm	RNS	Initiates Ph3 Pivotal Study of Epidiolex in LGS
11th May 2015	11:45 am	RNS	Holding(s) in Company
11th May 2015	11:45 am	RNS	Holding(s) in Company
8th May 2015	4:22 pm	RNS	Holding(s) in Company
6th May 2015	12:00 pm	RNS	Notice of Results
6th May 2015	12:00 pm	RNS	Initiates Phase 2 Trial of CBDV in Epilepsy
6th May 2015	7:01 am	RNS	Closing of U.S. Public Offering of ADSs
1st May 2015	3:28 pm	RNS	Holding(s) in Company
1st May 2015	7:30 am	RNS	Holding(s) in Company
29th Apr 2015	7:00 am	RNS	Pricing of U.S. Public Offering of ADSs
28th Apr 2015	7:00 am	RNS	Proposed Public Offering of ADSs
27th Apr 2015	12:00 pm	RNS	US Patent Allowance for Use of Cannabidivarin
24th Apr 2015	12:00 pm	RNS	Orphan Drug Designation for CBD in NHIE
23rd Apr 2015	7:00 am	RNS	New Physician Reports of Epidiolex Treatment
21st Apr 2015	12:00 pm	RNS	Starts 2nd Ph 3 Epidiolex Trial in Dravet Syndrome
14th Apr 2015	7:00 am	RNS	New Epidiolex Data Released by AAN
1st Apr 2015	2:03 pm	RNS	Holding(s) in Company
31st Mar 2015	12:00 pm	RNS	Starts Ph 3 Trial for Epidiolex in Dravet Syndrome
17th Mar 2015	5:18 pm	RNS	Holding(s) in Company
17th Mar 2015	5:15 pm	RNS	Holding(s) in Company
25th Feb 2015	12:00 pm	RNS	Presenting at Upcoming Investor Conferences
17th Feb 2015	3:25 pm	RNS	Blocklisting Interim Review
16th Feb 2015	3:52 pm	RNS	Holding(s) in Company
16th Feb 2015	3:48 pm	RNS	Holding(s) in Company
9th Feb 2015	5:31 pm	RNS	Director/PDMR Shareholding
5th Feb 2015	2:25 pm	RNS	Result of AGM
5th Feb 2015	12:00 pm	RNS	Presents at Leerink Global Healthcare Conference
4th Feb 2015	12:01 pm	RNS	1st Quarter Results

Latest Share Chat

GWP.L Regulatory News (GWP)

Additional Listing

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending